189 related articles for article (PubMed ID: 25574915)
61. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
[TBL] [Abstract][Full Text] [Related]
62. Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China.
Zhao B; Liu C; Fan J; Ma A; He W; Hu Y; Zhao Y
Microbiol Spectr; 2022 Oct; 10(5):e0240521. PubMed ID: 36214695
[TBL] [Abstract][Full Text] [Related]
63. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
[TBL] [Abstract][Full Text] [Related]
64. Community-based treatment for multidrug-resistant tuberculosis in rural KwaZulu-Natal, South Africa.
Heller T; Lessells RJ; Wallrauch CG; Bärnighausen T; Cooke GS; Mhlongo L; Master I; Newell ML
Int J Tuberc Lung Dis; 2010 Apr; 14(4):420-6. PubMed ID: 20202299
[TBL] [Abstract][Full Text] [Related]
65. Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.
Manabe YC; Hermans SM; Lamorde M; Castelnuovo B; Mullins CD; Kuznik A
PLoS One; 2012; 7(6):e39187. PubMed ID: 22723960
[TBL] [Abstract][Full Text] [Related]
66. Direct Detection by the Xpert MTB/RIF Assay and Characterization of Multi and Poly Drug-Resistant Tuberculosis in Guinea-Bissau, West Africa.
Rabna P; Ramos J; Ponce G; Sanca L; Mané M; Armada A; Machado D; Vieira F; Gomes VF; Martins E; Colombatti R; Riccardi F; Perdigão J; Sotero J; Portugal I; Couto I; Atouguia J; Rodrigues A; Viveiros M
PLoS One; 2015; 10(5):e0127536. PubMed ID: 26017968
[TBL] [Abstract][Full Text] [Related]
67. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
[TBL] [Abstract][Full Text] [Related]
68. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
69. Global burden of disease due to rifampicin-resistant tuberculosis: a mathematical modeling analysis.
Menzies NA; Allwood BW; Dean AS; Dodd PJ; Houben RMGJ; James LP; Knight GM; Meghji J; Nguyen LN; Rachow A; Schumacher SG; Mirzayev F; Cohen T
Nat Commun; 2023 Oct; 14(1):6182. PubMed ID: 37794037
[TBL] [Abstract][Full Text] [Related]
70. Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.
Wolfson LJ; Walker A; Hettle R; Lu X; Kambili C; Murungi A; Knerer G
PLoS One; 2015; 10(3):e0120763. PubMed ID: 25794045
[TBL] [Abstract][Full Text] [Related]
71. The treatment journey of a patient with multidrug-resistant tuberculosis in South Africa: is it patient-centred?
Loveday M; Padayatchi N; Voce A; Brust J; Wallengren K
Int J Tuberc Lung Dis; 2013 Oct; 17(10 Suppl 1):56-59. PubMed ID: 24020603
[TBL] [Abstract][Full Text] [Related]
72. The impact and cost-effectiveness of strategies to detect drug-resistant tuberculosis.
Oxlade O; Falzon D; Menzies D
Eur Respir J; 2012 Mar; 39(3):626-34. PubMed ID: 21828030
[TBL] [Abstract][Full Text] [Related]
73. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.
Espinal MA; Kim SJ; Suarez PG; Kam KM; Khomenko AG; Migliori GB; Baéz J; Kochi A; Dye C; Raviglione MC
JAMA; 2000 May; 283(19):2537-45. PubMed ID: 10815117
[TBL] [Abstract][Full Text] [Related]
74. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey.
Günther G; Gomez GB; Lange C; Rupert S; van Leth F;
Eur Respir J; 2015 Apr; 45(4):1081-8. PubMed ID: 25395035
[TBL] [Abstract][Full Text] [Related]
75. Factors contributing to the high prevalence of multidrug-resistance/Rifampicin-resistance in patients with tuberculosis: an epidemiological cross sectional and qualitative study from Khabarovsk krai region of Russia.
Bykov I; Dyachenko O; Ratmanov P; Liu H; Liang L; Wu Q
BMC Infect Dis; 2022 Jul; 22(1):612. PubMed ID: 35831812
[TBL] [Abstract][Full Text] [Related]
76. Comparing multidrug-resistant tuberculosis patient costs under molecular diagnostic algorithms in South Africa.
du Toit E; Squire SB; Dunbar R; Machekano R; Madan J; Beyers N; Naidoo P
Int J Tuberc Lung Dis; 2015 Aug; 19(8):960-8. PubMed ID: 26162363
[TBL] [Abstract][Full Text] [Related]
77. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.
Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E
PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569
[TBL] [Abstract][Full Text] [Related]
78. Latent tuberculosis infection in children: a call for revised treatment guidelines.
Finnell SM; Christenson JC; Downs SM
Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
[TBL] [Abstract][Full Text] [Related]
79. Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.
Cox H; Dickson-Hall L; Ndjeka N; Van't Hoog A; Grant A; Cobelens F; Stevens W; Nicol M
PLoS Med; 2017 Feb; 14(2):e1002238. PubMed ID: 28222095
[TBL] [Abstract][Full Text] [Related]
80. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
